HIV drug study reveals immune impact on newborns
NCT ID NCT04024150
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 27 times
Summary
This study examined 29 newborns to see if exposure to a class of HIV drugs called anti-integrases in the womb changes their immune system at birth. Researchers compared babies whose mothers took anti-integrase drugs with those whose mothers took other HIV medications. The goal was to understand any differences in immune cell diversity, not to test a treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTI-INTEGRASES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
AP-HP, Hôpital Bichat-Claude Bernard
Paris, 75018, France
-
AP-HP, Hôpital Cochin
Paris, 75014, France
-
AP-HP, Hôpital Louis Mourier
Colombes, 92700, France
-
AP-HP, Hôpital Necker
Paris, 75015, France
-
AP-HP, Hôpital de la Pitié Salpêtrière
Paris, 75013, France
Conditions
Explore the condition pages connected to this study.